Pain and fatigue in systemic sclerosis are common but often overlooked. New evidence highlights non-drug strategies, ...
Cell therapy may represent a new frontier in the treatment of autoimmune diseases, with the majority of US rheumatologists reporting highly favorable impressions of emerging data, according to Spherix ...
Please provide your email address to receive an email when new articles are posted on . Nearly 10% of patients with systemic sclerosis had systemic sclerosis sine scleroderma, a subtype without skin ...
Patients with interstitial lung disease in systemic sclerosis demonstrate distinct intestinal microbiota that may help identify pathogenesis and targeted treatments, according to data published in ...
Systemic sclerosis (SSc) is a rare autoimmune disease that can harden the skin, impair blood flow, and damage internal organs such as the lungs and kidneys. But no two patients experience the disease ...
AMSTERDAM — For patients with diffuse cutaneous systemic sclerosis, an autoimmune disease for which there are few treatment options, lenabasum (JBT-101, Corbus Pharmaceuticals) shows potential, new ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Episodes of ...
The "Systemic Scleroderma Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com’s ...
The thought of having one or both lungs replaced may sound overwhelming, but it's improved the lives of thousands of people ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback